SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-029110
Filing Date
2018-11-13
Accepted
2018-11-13 07:13:06
Documents
64
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q surf-10q_20180930.htm 10-Q 1841890
2 EX-10.1 surf-ex10_37.htm EX-10 22810
3 EX-10.2 surf-ex10_36.htm EX-10 443145
4 EX-31.1 surf-ex311_6.htm EX-31.1 18658
5 EX-32.1 surf-ex321_7.htm EX-32.1 7874
6 GRAPHIC g4xorwlunwct000001.jpg GRAPHIC 3650
  Complete submission text file 0001564590-18-029110.txt   7289943

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT surf-20180930.xml EX-101.INS 1617031
8 XBRL TAXONOMY EXTENSION SCHEMA surf-20180930.xsd EX-101.SCH 40593
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE surf-20180930_cal.xml EX-101.CAL 37787
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE surf-20180930_def.xml EX-101.DEF 147208
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE surf-20180930_lab.xml EX-101.LAB 329899
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE surf-20180930_pre.xml EX-101.PRE 275850
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38459 | Film No.: 181175053
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1